Dr. Howard Alan Fine

Dr. Howard A. Fine, MD, is a renowned neuro-oncologist and trailblazing physician–scientist who directs the Brain Tumor Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital. He also holds the position of Professor of Neurology at Weill Cornell and leads its Neuro-Oncology Program. Dr. Fine received his medical degree from the Icahn School of Medicine at Mount Sinai, completed his internal medicine residency at Columbia University, and pursued fellowship training in medical oncology and neuro-oncology at the National Cancer Institute. Board-certified in internal medicine and medical oncology, he brings over three decades of expertise in managing primary brain tumors, particularly glioblastomas and diffuse gliomas.

A globally recognized leader in the field of brain tumor research, Dr. Fine is known for his pioneering work in molecular and stem cell biology of gliomas. His efforts have significantly influenced the evolution of targeted therapy and precision medicine approaches in neuro-oncology. He has played a central role in the development of novel preclinical tumor models and personalized treatment strategies that are now being translated into innovative clinical trials. With over 250 scientific publications and numerous federal and private research grants, Dr. Fine’s scholarly output has shaped the direction of neuro-oncology research on a national and international level.

In addition to his research and clinical contributions, Dr. Fine is a dedicated educator and mentor to the next generation of physician–scientists. Prior to joining Weill Cornell, he held leadership roles at the National Institutes of Health and Dana-Farber Cancer Institute, helping define the national agenda for neuro-oncology care and discovery. His active involvement in advisory panels, editorial boards, and national cancer research initiatives underscores his influence across academic medicine. Through his innovative work, compassionate patient care, and unwavering commitment to advancing the field, Dr. Fine remains one of the most respected authorities in neuro-oncology today.